相关实验视频

Updated: Jun 18, 2026

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

15.3K

乙素和免疫检查点抑制剂在多种癌症中的有效性:一项回顾性研究

Risako Suzuki1,2,3, Ryotaro Ohkuma1,2,4, Makoto Watanabe2,3,5,6

  • 1Department of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo 142-8666, Japan.

Biomedicines
|December 30, 2025
PubMed
概括

在接受免疫检查点抑制剂 (ICI) 单一治疗的患者中,更高的基线乙氨基酸细胞计数预测了更好的生存率. 这一发现表明,乙素可能是ICI有效性的有用预测生物标志物.

关键词:
在NLR中,它是NLR.生物标志物生物标志物爱因素的 爱因素的免疫检查点抑制剂总体存活率 总体存活率没有进展的生存率.这是一项回顾性研究.

更多相关视频

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

6.1K
Predictive Immune Modeling of Solid Tumors08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.4K

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.